Cullinan Therapeutics, Inc. (CGEM)

NASDAQ

$14.12

$-0.25

(-1.71%)

Pre-Market

Cullinan Therapeutics, Inc. (CGEM) Live Price Chart

Last updated: ⁦2026-10-14 12:57:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Cullinan Therapeutics, Inc. (CGEM) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $14.12, with a market capitalisation of $962.10M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $6.73 to $23.19. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$962.10M
Open	$14.37
Day's High	$59.85
Day's Low	$5.68
Previous Close	$14.10
Volume	3.61K
Average Volume	880.91K
P/E Ratio	--
52-Week High	$23.19
52-Week Low	$6.73
Dividend Yield	--
Earnings Date	--

Cullinan Therapeutics, Inc. (CGEM) Pre-Market Stock Price

Cullinan Therapeutics, Inc. (CGEM) is trading at $14.12 in pre-market trading as of 2026-10-14 12:54:00, up 0.16% ($0.02) from the previous close of $14.10

Pre-market trading shows how investors are pricing CGEM before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Cullinan Therapeutics, Inc. (CGEM) 7-Day Stock Price Change

Over the past seven days, Cullinan Therapeutics, Inc. (CGEM) moved from $16.04 to $14.12, representing a decline of 11.96% ($1.92).

The stock traded between $13.95 and $17.70 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 939.45 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

CGEM 52-Week Price Position

Position in Range: 44.9%

52W Low$6.73

52W High$23.19

CGEM is currently trading at $14.12, placing it 44.9% of the way from its 52-week low of $6.73 to its 52-week high of $23.19. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Cullinan Therapeutics, Inc. (CGEM)?

Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its development pipeline comprises the following drug candidates: CLN-978, a CD19xCD3 bispecific T cell engager that is being developed for autoimmune diseases; CLN-049, a FLT3xCD3 bispecific T cell engager being evaluated in an ongoing clinical trial in patients with relapsed/refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS); Velinotamig, a BCMAxCD3 bispecific T cell engager being developed to counter autoimmune diseases; and Zipalertinib, being developed as a treatment for non-small cell lung cancer. Additionally, the company is developing several preclinical programs in autoimmune diseases and oncology.

Cullinan Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	109
Exchange	NASDAQ
Company Website	https://www.cullinantherapeutics.com

How to Buy Cullinan Therapeutics, Inc. (CGEM) Stock on MEXC

Eligible investors can buy real shares of Cullinan Therapeutics, Inc. (CGEM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CGEM and Place Your Order

Open the RealStocks trading page and search for CGEM. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Cullinan Therapeutics, Inc. (CGEM) stock price today?

Cullinan Therapeutics, Inc. (CGEM) is currently trading at $ 14.12, up 0.16% ($0.02) from the previous close of $ 14.10. Intraday prices update in real time during regular trading hours.

2.Is CGEM stock going up or down today?

As of 2026-10-14 12:54:00, CGEM is trading at $ 14.12, up 0.16% ($0.02) from its previous close of $ 14.10. The stock has traded between $ 5.68 and $ 59.85 during today’s regular session. Past price movements do not guarantee future results.

3.What is CGEM pre-market price?

As of 2026-10-14 12:54:00, CGEM is trading at $ 14.12 in pre-market trading, up 0.16% ($0.02) from the previous close of $ 14.10. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CGEM after-hours price?

As of 2026-10-14 12:54:00, CGEM is trading at $ 14.39 in after-hours trading, up 2.06% ($0.29) from the regular-session close of $ 14.10. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CGEM stock trading now?

CGEM trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CGEM sit relative to its 52-week high and low?

Over the past 52 weeks, CGEM has traded between a low of $ 6.73 and a high of $ 23.19. At $ 14.12, the stock is positioned 44.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Cullinan Therapeutics, Inc. in?

Cullinan Therapeutics, Inc. (CGEM) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Cullinan Therapeutics, Inc.'s market capitalisation and where is it listed?

Cullinan Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 962.10M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CGEM valued in terms of P/E ratio and EPS?

CGEM trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.78. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Cullinan Therapeutics, Inc. pay a dividend?

Cullinan Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.